Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Home/Retail & Consumer Discretionary/Tata Consumer Products DCF Valuation April 2026
Retail & Consumer Discretionary

Tata Consumer Products DCF Valuation April 2026

By Zumedha Research Team on April 25, 2026 9 Min Read
Tata Consumer Products — Zumedha Equity Research
Zumedha Equity Research
Research  ·  Analysis  ·  Insights
Current Market Price
₹1,184
as on 23 Apr 2026
ACCUMULATE
Tata Consumer Products Limited
India’s emerging FMCG giant — Beverages · Foods · Nutrition · International | NSE: TATACONSUM · BSE: 500800
NSETATACONSUM
BSE500800
ISININE192A01025
Face Value₹1
52W H/L₹1,220 / ₹930
Mkt Cap₹1,09,500 Cr
Shares92.5 Cr
IndexNifty 50 · Nifty FMCG
Promoter33.84%
FII21.19%
01 Business Overview

Tata Consumer Products (TCPL) is the Tata Group’s consolidation vehicle for all consumer-facing food and beverage assets — spanning tea, coffee, salt, packaged foods, ready-to-drink beverages, and international grocery. Formed through the 2020 merger of Tata Global Beverages with Tata Chemicals’ consumer business, it is now India’s second-largest FMCG company by market cap and the world’s second-largest branded tea company.

Revenue (FY25)
₹17,619 Cr
+16% YoY
EBITDA (FY25)
₹2,502 Cr
+8% YoY
PAT (FY25)
₹1,287 Cr
+6% YoY
EBITDA Margin
14.2%
Q3 FY26 peak
ROE (3yr avg)
7.4%
Below sector norm
Promoter Stake
33.84%
Steady; Tata Sons

TCPL’s portfolio architecture is bifurcated into a core business (Tata Tea, Tata Salt, Tetley, Eight O’Clock Coffee) generating durable annuity-like revenues, and a high-growth adjacency engine (Tata Sampann, Tata Soulfull, Capital Foods — Ching’s Secret & Smith & Jones, Organic India, Tata Starbucks JV, Nourishco RTD). The growth businesses crossed ₹3,200 Cr of India revenue in FY25, representing 28% of the India business.

Geographically, TCPL operates across India (~65% of consolidated revenue), the UK (Tetley — historic highs on EBITDA margin), USA (Eight O’Clock Coffee gaining market share), Canada (Tetley — fastest growing specialty tea), and 40+ other markets. International business delivered constant-currency growth of 5% in FY25 and 11% in Q3 FY26, led by coffee momentum in North America. The Tata Starbucks JV now spans 504 stores across 81 cities.


02 Historical Financials — Consolidated
Metric (₹ Cr)FY21FY22FY23FY24FY259M FY26
Revenue11,60212,01813,78315,20617,61915,222
YoY Growth—3.6%14.7%10.3%15.9%~16% ann.
Gross Profit4,8204,8905,2006,0907,150~5,800e
Gross Margin41.5%40.7%37.7%40.0%40.6%~38.1%
EBITDA1,6261,6981,8762,3232,5022,130
EBITDA Margin14.0%14.1%13.6%15.3%14.2%~14.0%
Depreciation480520568620680~530e
EBIT1,1461,1781,3081,7031,822~1,600e
PAT (reported)6927901,0161,2131,2871,128
PAT Growth—14.2%28.6%19.4%6.1%+20%e ann.
EPS (₹)7.99.011.513.714.5~12.8 (9M)
Dividend (₹)3.754.255.507.758.25—

Revenue has compounded at approximately 11% CAGR over FY21–FY25, accelerating to 16% in FY25 — aided by the Capital Foods and Organic India acquisitions (~₹1,500 Cr annualised revenue addition). Organic growth ex-acquisitions was ~10% in FY25. EBITDA has grown at 11.4% CAGR over the same period though margins dipped in FY25 vs. FY24 peak due to tea cost inflation and acquisition integration drag. PAT growth has been lower at ~17% CAGR due to elevated D&A from acquired intangibles and finance costs from acquisition debt.

Returns & EfficiencyFY21FY22FY23FY24FY25
ROE (%)5.86.27.98.87.4
ROCE (%)6.57.09.110.29.0
Asset Turnover (x)0.550.540.580.610.65
Net Debt / EBITDA0.40.20.10.90.7
Working Capital Days3235384138

The core profitability challenge: TCPL’s ROE at 7.4% (3-year average) and ROCE at ~9% are structurally low for a premium-rated FMCG franchise. This is the Achilles heel of the bull case — the company is trading at 86x trailing P/E but generating sub-10% return on capital. The root cause is large goodwill/intangibles from the Tata Chemicals merger, Capital Foods acquisition (₹5,100 Cr), and Organic India acquisition (₹1,000 Cr+), which inflate the capital base.


03 DCF Valuation — 10-Year Free Cash Flow Model
Discounted Cash Flow — Base Case Assumptions
12.0%
5.0%
14.5%
₹950
YearRevenue (Cr)EBITDA MarginEBITDA (Cr)FCF (Cr)Discount FactorPV of FCF (Cr)
FY26E20,25014.2%2,8761,3800.8931,232
FY27E23,40014.8%3,4631,7200.7971,371
FY28E26,80015.3%4,1002,0900.7121,488
FY29E30,20015.8%4,7722,5100.6361,596
FY30E33,90016.2%5,4922,9600.5671,679
FY31E37,50016.5%6,1883,3800.5071,714
FY32–35ETapering16.5%—~14,200Blended6,800
Terminal Value———FCF₃₅ × (1+g)/(WACC−g)0.21518,400
Intrinsic Value Bridge:  Sum of PV of FCFs ≈ ₹33,880 Cr + Terminal Value PV ≈ ₹18,400 Cr → Enterprise Value ≈ ₹52,280 Cr → Less net debt (~₹2,800 Cr) + Minority interests adj. → Equity Value ≈ ₹87,800 Cr → Per Share ≈ ₹950 (on 92.5 Cr diluted shares). Model embeds 14.5% revenue CAGR in Phase I (FY26–31), decelerating to 10% in Phase II and 5% terminal, with margin expansion from 14.2% to 16.5% driven by operating leverage on the foods portfolio and international recovery. At CMP ₹1,184, the stock trades at a 24.6% premium to DCF fair value, reflecting brand optionality and Tata Group franchise premium that the model partially excludes.

04 Buy Range — Entry Zones
Strong Buy Zone
₹850 – ₹920
~15% discount to DCF; 50x FY27E P/E. High margin of safety; ideal accumulation.
Accumulate Zone
₹920 – ₹1,050
DCF fair value band; 55–62x FY27E P/E. Patient buyer’s entry.
Fair Value Entry
₹1,050 – ₹1,150
Near intrinsic value + reasonable growth premium. Acceptable for SIPs.

At CMP ₹1,184, the stock sits above all three buy zones — a clear signal that near-term margin of safety is thin. The stock touched a 52-week low of ₹930 in March 2025 (precisely our Strong Buy Zone) before rallying ~27%. Investors with a 3-year horizon may consider partial accumulation at current levels with the expectation of FY27 earnings re-rating, but the optimal window is ₹950–₹1,050 — which may re-emerge around Q4 FY26 results if margins disappoint.


05 Buy Scenario Analysis — 24-Month Target
Bear Case
₹880
FY27E PAT ₹1,500 Cr · 55x P/E · Margin stagnation; tea cost spike; acquisition drag persists; ROE stays sub-8%.
Base Case
₹1,300
FY27E PAT ₹1,900 Cr · 68x P/E · 15% revenue growth; EBITDA margin 15%; acquisitions fully accretive by FY27.
Bull Case
₹1,600
FY27E PAT ₹2,200 Cr · 73x P/E · Foods portfolio outperforms; RTD scales; UK restructuring drives international margin; ROE inflects.

The base case assumes analyst consensus of 26% PAT growth in FY26 (on TTM basis) and further acceleration in FY27 as operating leverage from the acquisitions kicks in. Key re-rating triggers: (a) EBITDA margin crossing 16% sustainably — signalling that Capital Foods/Organic India have diluted margin drag is over; (b) ROE trajectory crossing 10%; (c) management FY27 guidance at ≥15% revenue growth on Q4 FY26 results call.


06 Sell Range — Exit Zones
Reduce Zone
₹1,350 – ₹1,500
70–78x FY27E P/E. Trim 30–40% of position. Valuation pricing in perfection.
Exit Zone
₹1,500 – ₹1,650
78–85x FY27E P/E. Exit majority. Priced beyond bull case scenario.
Avoid / Short
₹1,650+
>85x FY27E P/E. Structural overvaluation. Historical re-rating risk is extreme.

07 Sell Scenario Analysis — Exit Triggers
Overvalued
₹1,350+
EBITDA margin <14% for two consecutive quarters; PAT growth <10% in FY27E; acquisition intangible impairment risk.
Exit Trigger
₹1,500+
Management cuts FY27 guidance; ROE fails to cross 9%; competitive intensity erodes tea/salt pricing power materially.
Structural Break
₹1,650+
Tata Starbucks JV pressured by slowing discretionary; private label disruption in core tea/salt; sustained FII outflows.

08 Future Growth & Earnings Outlook
MetricFY25AFY26EFY27EFY28E3yr CAGR
Revenue (Cr)17,61920,25023,40026,80014.9%
EBITDA (Cr)2,5022,8763,4634,10017.8%
EBITDA Margin14.2%14.2%14.8%15.3%+110 bps
PAT (Cr)1,2871,6251,9502,38022.8%
EPS (₹)14.518.322.026.822.8%
P/E (at CMP ₹1,184)81.7x64.7x53.8x44.2xDe-rating path
ROE (%)7.48.510.212.0Improving
ROCE (%)9.010.512.014.0Improving
FCF (Cr)~900~1,380~1,720~2,09032% CAGR

The earnings story is fundamentally a growth-to-profitability flywheel. TCPL has spent FY23–FY25 investing aggressively — two transformative acquisitions, GTM expansion (35% more feet on street via split routes), store rollout at Tata Starbucks, and category creation in RTD. These are sunk costs that should generate leverage from FY26 onwards. Q3 FY26 provided the first credible evidence: EBITDA grew 26% on 15% revenue growth — classic operating leverage.

The analyst consensus from 28 brokerages projects 13.9% revenue growth and 26.4% PAT growth for FY26, with Motilal Oswal maintaining a Buy with a target of ₹1,370. The FCF generation story is more compelling than the P&L — FCF is estimated to triple from ~₹900 Cr in FY25 to ~₹2,090 Cr by FY28 as capex intensity normalises and working capital cycles improve. This will structurally de-leverage the balance sheet and begin improving return ratios — the single most important re-rating catalyst for TCPL.

India Foods acceleration is the optionality the market is paying for. Tata Sampann grew 29% in Q3 FY26 and Tata Soulfull grew 32% in FY25. Capital Foods (Ching’s Secret) is now in GTM rollout across modern trade and e-commerce. If the combined foods portfolio reaches ₹8,000–10,000 Cr in revenue by FY29 (from ~₹3,200 Cr in FY25), the EBITDA mix will improve materially — foods carry structurally higher margins than beverages.


09 Risks & Catalysts
Bull Catalysts
EBITDA margin expansion above 15% in FY27 — confirms acquisition drag is over and operating leverage is real
ROE trajectory crosses 10% — structural re-rating from low-return FMCG to quality compounder
Capital Foods / Organic India synergies accelerate: foodservice, pharma channels add ₹1,000 Cr+ by FY28
Tea cost tailwind: Indian black tea prices cyclically correcting — gross margin expansion in core beverages
India RTD (Nourishco) scales to ₹2,000 Cr+ — plays on health, hydration, and premiumization megatrends
International margins hit historic highs in UK; Eight O’Clock Coffee gains share in the US premium segment
Tata Starbucks crosses 600 stores — JV profitability turns positive, accretive to consolidated ROE
Bear Risks
Tea cost spike: El Niño-driven supply disruptions could compress gross margins in the core India beverages business
Acquisition impairment: Capital Foods at ~5x EV/Sales carried significant goodwill; underperformance triggers write-down
Return ratio stagnation: If acquisitions don’t accrete by FY27, the ROE story collapses and 80x+ P/E is unjustifiable
Coffee cost inflation internationally (Q2 FY26 saw 40% coffee cost surge) — continuing pressure on international margins
Competitive intensity in salt/tea from regional players and private labels limiting pricing power
FII outflows: 21% FII holding with marginal decline trend — global risk-off could drive meaningful selling
India FMCG consumption slowdown — urban demand pressure observed across peer set in H1 FY26

10 Peer Comparison — Indian FMCG Universe
CompanyMkt Cap (Cr)Revenue (Cr)EBITDA MgPAT GrowthP/E (TTM)EV/EBITDAP/BROE (%)ROCE (%)Rating
Tata Consumer Products1,09,50017,61914.2%26%E81.7x44.3x5.5x7.4%9.0%ACCUMULATE
Hindustan Unilever5,10,00060,54023.5%8%52x34x10.2x19.5%28.0%HOLD
Nestlé India1,32,00018,47022.8%12%65x40x52.0x82.0%115%HOLD
Britannia Industries90,00016,89018.0%10%48x29x25.5x50.0%68.0%HOLD
Godrej Consumer Products96,00014,20022.0%18%55x35x7.5x14.0%18.0%BUY
Dabur India76,00012,80020.0%9%44x28x7.8x18.0%22.0%HOLD
ITC Limited3,50,00078,00038.0%5%26x17x6.2x24.0%32.0%BUY

Valuation context: TCPL’s P/E of 82x and EV/EBITDA of 44x sit at a significant premium versus category leaders (HUL: 52x P/E, Britannia: 48x P/E) — paradoxically despite inferior ROE and ROCE. The premium is justified on a forward basis if the earnings growth materialises at 22–26%: TCPL’s FY27E P/E declines to 54x, narrowing the gap. However, TCPL’s ROE/ROCE remain meaningfully below peers — HUL at 19.5%/28%, Britannia at 50%/68%, Nestlé at 82%/115% — because those franchises don’t carry large acquired goodwill. This is a structural discount factor that will persist until goodwill amortises or PAT scales significantly.

The appropriate FMCG peer for TCPL is arguably not HUL or Nestlé (mature, high-return) but rather a faster-growing platform like Godrej Consumer (55x, 18% PAT growth) which has a better risk/reward at current valuations. TCPL’s premium to GCPL is ~50% on P/E but GCPL offers comparable growth with superior return ratios — a genuine valuation gap investors should weigh.


ZUMEDHA VERDICT

Tata Consumer Products is a high-quality franchise at a high-quality price. The business transformation story — from a legacy tea company to a multi-category FMCG platform — is genuine and strategically compelling. Volume-led growth of 15% in Q3 FY26, EBITDA expansion of 26%, and the India Foods engine accelerating confirm the thesis. However, at ₹1,184 — 81x trailing earnings, 44x EV/EBITDA, and 24% above DCF fair value — the margin of safety is thin. The stock is priced for flawless execution.

Our rating is ACCUMULATE — not a full Buy — with the ideal entry zone between ₹950 and ₹1,050. Investors with a 3-year horizon can initiate partial positions at current levels via SIP mode, with the understanding that the re-rating catalyst is a sustained ROE trajectory above 10% (expected by FY27E) and EBITDA margin expansion above 15%. We set a 12-month base case target of ₹1,300 and a bull case of ₹1,600 contingent on FY27 earnings delivery. Any pullback to ₹1,000–1,050 should be aggressively accumulated.
ACCUMULATE 12M Target: ₹1,300 Bull: ₹1,600 | Bear: ₹880 Upside (Base): +9.8%
Disclaimer — This report is produced by Zumedha Equity Research solely for informational and educational purposes. It does not constitute investment advice, a solicitation to buy or sell, or a recommendation of any security. All financial data is sourced from publicly available company filings, exchange disclosures, and third-party databases. Estimates and projections are Zumedha’s own and are subject to change without notice. Past performance of any security is not indicative of future results. Readers are strongly advised to conduct their own due diligence and consult a SEBI-registered investment adviser before making any investment decision. Zumedha Equity Research and its associates may or may not hold positions in the securities mentioned. Market prices, financial data, and analyst estimates referenced herein are as of 23 April 2026 and may have changed. The CMP used for all valuation analysis is ₹1,184 (as on 23 Apr 2026). This document is the intellectual property of Zumedha Equity Research and may not be reproduced without explicit written permission.
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

Solar Industries India Limited (SIIL) Share Price Analysis April 2026

Next

Cyient Ltd DCF Valuation Share Price April 2026

Legal Disclaimer Investment Research & Information

Not Investment Advice. All content published on this website — including stock analyses, mutual fund reviews, DCF models, valuation estimates, buying zones, and commentary — is created for our own educational, internal research and informational purposes only. Nothing on this website constitutes financial, investment, legal, or tax advice, nor a solicitation or recommendation to buy, sell, or hold any security or financial instrument.

No Guarantees. It is advised clearly and categorically not o follow these analysis and information blindly for your equity investement purpose as Equity investments and mutual funds are subject to market risks. Past performance is not indicative of future results. All DCF models, fair value estimates, and scenario analyses are based on publicly available data and the author's independent assumptions and may prove materially incorrect. The author/s or owners of this website/portal do not are not liable in whatsoever manner for any positive or negative outcome from your own investment endeavorsYou may lose part or all of your invested capital.

Do Your Own Research. Readers are strongly advised to consult a SEBI-registered investment advisor and conduct their own due diligence before making any investment decision. The author may or may not hold positions in securities discussed on this website.

No Obligations. We, the author/ the publisher/ anybody associated with Zumedha.com does not guarantee the accuracy, adequacy or completeness of any information/data and is not responsible for any errors or omissions or for the results obtained from the use of such information/data. Zumedha.com or anyone involved with zumedha.com will not accept any liability for loss or damage as a result of reliance on the Estimates data. It does not subscribe or endorse any of the services and/or content offered by such third party.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
This website is not registered as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013. All views are personal and for informational purposes only.
© 2026 · All Rights Reserved · For Educational Use Only. RESEARCH · ANALYSIS · INSIGHTS